Exact Sciences Share Price Today
(NASDAQ: EXAS)

Name: Exact Sciences Share Price Today (NASDAQ: EXAS) - Exact Sciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Exact Sciences share price is $56.05 & ₹4,856.17 as on 1 Feb 2025, 2.30 'hrs' IST

$56.05

▲

0.02

(0.04%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Exact Sciences share price in Dollar and Rupees. Guide to invest in Exact Sciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Exact Sciences, along with analyst recommendations, forecasts, and comprehensive financials.

Exact Sciences share price movements

Today's Low: $55.43
Today's High: $57.21
$56.05
1.12%
Downside
Day's Volatility :3.12%
Upside
2.03%
52 Weeks Low: $40.62
52 Weeks High: $79.62
$56.05
27.52%
Downside
52 Weeks Volatility :48.98%
Upside
29.6%

Exact Sciences (EXAS) Returns

Period	Exact Sciences Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.23%	0.3%	0.0%
6 Months	0.47%	-1.5%	0.0%
1 Year	-12.52%	5.0%	0.0%
3 Years	-26.12%	12.3%	-12.8%

Exact Sciences (EXAS) Key Statistics

in dollars & INR

Previous Close	$56.03
Open	$56.48
Today's High	$57.21
Today's Low	$55.425
Market Capitalization	$10.4B
Today's Volume	$1.3M
52 Week High	$79.62
52 Week Low	$40.624
Revenue TTM	$2.7B
EBITDA	$-11.3M
Earnings Per Share (EPS)	$-1.16
Profit Margin	-7.95%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-6.76%

How to invest in Exact Sciences Stock (EXAS) from India?

It is very easy for Indian residents to invest directly in Exact Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Exact Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Exact Sciences or EXAS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Exact Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Exact Sciences shares which would translate to 0.015 fractional shares of Exact Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Exact Sciences, in just a few clicks!

Returns in Exact Sciences (EXAS) for Indian investors in Rupees

The Exact Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Exact Sciences investment value today

Current value as on today

₹91,929

Returns

₹8,071

(-8.07%)

Returns from Exact Sciences Stock

₹12,490 (-12.49%)

Dollar Returns

₹4,419 (+4.42%)

Indian investors sentiment towards Exact Sciences (EXAS)

57.5%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Investment in Exact Sciences Shares from India has grown by 57.5% over the past 30 days, indicating increased transactional activity.

-62%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Exact Sciences Stock from India on INDmoney has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Exact Sciences

FMR Inc
11.70%
Vanguard Group Inc
9.60%
Capital World Investors
8.56%
Wellington Management Company LLP
7.74%
BlackRock Inc
6.09%
State Street Corp
3.61%

Analyst Recommendation on Exact Sciences

Buy

89%Buy

10%Hold

0%Sell

Based on 29 Wall street analysts offering stock ratings for Exact Sciences(by analysts ranked 0 to 5 stars)

Based on 29 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Exact Sciences Stock (EXAS)

What analysts predicted

Upside of 28.79%

Target:

$72.19

Current:

$56.05

Insights on Exact Sciences Stock (Ticker Symbol: EXAS)

Price Movement
In the last 3 months, EXAS stock has moved down by -18.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 637.52M → 708.65M (in $), with an average increase of 5.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.80M → -38.23M (in $), with an average decrease of 141.9% per quarter
EXAS vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 16.4% return, outperforming this stock by 30.7%
EXAS vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 8.7% return, outperforming this stock by 35.3%
Price to Sales
ForEXAS every $1 of sales, investors are willing to pay $3.8, whereas for Agilent Technologies Inc., the investors are paying $6.8 for every $1 of sales.

EXAS Exact Sciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$454.5M	↑ 70.86%
Net Income	$-175.1M	↑ 53.11%
Net Profit Margin	-38.54%	↑ 4.47%

	FY19	Y/Y Change
Revenue	$876.3M	↑ 92.82%
Net Income	$-84.0M	↓ 52.04%
Net Profit Margin	-9.59%	↑ 28.95%

	FY20	Y/Y Change
Revenue	$1.5B	↑ 70.19%
Net Income	$-848.5M	↑ 910.24%
Net Profit Margin	-56.9%	↓ 47.31%

	FY21	Y/Y Change
Revenue	$1.8B	↑ 18.49%
Net Income	$-595.6M	↓ 29.81%
Net Profit Margin	-33.71%	↑ 23.19%

	FY22	Y/Y Change
Revenue	$2.1B	↑ 17.95%
Net Income	$-623.5M	↑ 4.68%
Net Profit Margin	-29.91%	↑ 3.8%

	FY23	Y/Y Change
Revenue	$2.5B	↑ 19.93%
Net Income	$-204.1M	↓ 67.26%
Net Profit Margin	-8.17%	↑ 21.74%

	Q2 FY23	Q/Q Change
Revenue	$622.1M	↑ 3.26%
Net Income	$-81.0M	↑ 9.27%
Net Profit Margin	-13.02%	↓ 0.71%

	Q3 FY23	Q/Q Change
Revenue	$628.3M	↑ 1.0%
Net Income	$794.0K	↓ 100.98%
Net Profit Margin	0.13%	↑ 13.15%

	Q4 FY23	Q/Q Change
Revenue	$646.9M	↑ 2.95%
Net Income	$-49.8M	↓ 6367.76%
Net Profit Margin	-7.69%	↓ 7.82%

	Q1 FY24	Q/Q Change
Revenue	$637.5M	↓ 1.45%
Net Income	$-110.2M	↑ 121.49%
Net Profit Margin	-17.29%	↓ 9.6%

	Q2 FY24	Q/Q Change
Revenue	$699.3M	↑ 9.68%
Net Income	$-15.8M	↓ 85.66%
Net Profit Margin	-2.26%	↑ 15.03%

	Q3 FY24	Q/Q Change
Revenue	$708.7M	↑ 1.34%
Net Income	$-38.2M	↑ 141.88%
Net Profit Margin	-5.4%	↓ 3.14%

	FY18	Y/Y Change
Profit	$336.5M	↑ 80.14%

	FY19	Y/Y Change
Profit	$659.6M	↑ 96.02%

	FY20	Y/Y Change
Profit	$1.1B	↑ 72.39%

	FY21	Y/Y Change
Profit	$1.3B	↑ 15.06%

	FY22	Y/Y Change
Profit	$1.5B	↑ 15.41%

	FY23	Y/Y Change
Profit	$1.8B	↑ 22.23%

	Q2 FY23	Q/Q Change
Profit	$465.1M	↑ 4.38%

	Q3 FY23	Q/Q Change
Profit	$459.8M	↓ 1.14%

	Q4 FY23	Q/Q Change
Profit	$475.1M	↑ 3.32%

	Q1 FY24	Q/Q Change
Profit	$467.4M	↓ 1.61%

	Q2 FY24	Q/Q Change
Profit	$486.1M	↑ 4.0%

	Q3 FY24	Q/Q Change
Profit	$512.6M	↑ 5.44%

	FY18	Y/Y Change
Operating Cash Flow	$-69.3M	↓ 3.34%
Investing Cash Flow	$-781.9M	↑ 386.25%
Financing Cash Flow	$934.1M	↑ 257.97%

	FY19	Y/Y Change
Operating Cash Flow	$-115.0M	↑ 65.9%
Investing Cash Flow	$-121.1M	↓ 84.52%
Financing Cash Flow	$253.2M	↓ 72.9%

	FY20	Y/Y Change
Operating Cash Flow	$136.5M	↓ 218.67%
Investing Cash Flow	$-702.0M	↑ 479.85%
Financing Cash Flow	$1.9B	↑ 642.4%

	FY21	Y/Y Change
Operating Cash Flow	$-102.2M	↓ 174.91%
Investing Cash Flow	$-1.1B	↑ 54.14%
Financing Cash Flow	$8.5M	↓ 99.55%

	FY22	Y/Y Change
Operating Cash Flow	$-223.6M	↑ 118.67%
Investing Cash Flow	$74.1M	↓ 106.84%
Financing Cash Flow	$76.5M	↑ 802.8%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$100.4M	↓ 362.79%
Investing Cash Flow	$66.5M	↓ 19.85%
Financing Cash Flow	$16.0M	↓ 87.99%

Exact Sciences Technicals Summary

Sell

Neutral

Buy

Exact Sciences is currently in a neutral trading position according to technical analysis indicators.

Exact Sciences (EXAS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Exact Sciences Corporation	-1.57%	0.47%	-12.52%	-26.12%	-40.75%
Agilent Technologies Inc.	13.45%	12.38%	13.85%	4.95%	84.27%
Idexx Laboratories, Inc.	3.7%	-6.83%	-19.57%	-20.64%	53.75%
Thermo Fisher Scientific, Inc.	16.11%	1.46%	9.95%	0.43%	90.59%
Danaher Corp.	-2.93%	-17.17%	-9.44%	-24.23%	38.56%
Iqvia Holdings Inc.	3.41%	-13.64%	-4.26%	-20.7%	29.97%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Exact Sciences Corporation	NA	NA	-1.07	-0.57	-0.07	-0.02	NA	17.35
Agilent Technologies Inc.	34.17	34.17	2.48	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	40.5	40.5	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	35.58	35.58	2.21	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	42.37	42.37	2.99	7.76	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.52	26.52	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Exact Sciences Corporation	Buy	$10.4B	-40.75%	NA	-7.95%
Agilent Technologies Inc.	Buy	$43.2B	84.27%	34.17	21.75%
Idexx Laboratories, Inc.	Buy	$34.3B	53.75%	40.5	22.53%
Thermo Fisher Scientific, Inc.	Buy	$217.3B	90.59%	35.58	14.48%
Danaher Corp.	Buy	$160.9B	38.56%	42.37	16.39%
Iqvia Holdings Inc.	Buy	$36.6B	29.97%	26.52	9.17%

Exact Sciences Dividend announcements

Exact Sciences Earnings
Exact Sciences’s price-to-earnings ratio stands at None
Read More

About Exact Sciences

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Organization	Exact Sciences
Employees	6500
CEO	Mr. Kevin T. Conroy J.D.
Industry	Health Technology

Management People of Exact Sciences

Name	Title
Mr. Kevin T. Conroy J.D.	Chairman of the Board & CEO
Mr. Jake Orville MBA	Executive VP & GM of Screening
Mr. Brian Baranick	Executive VP & General Manager of Precision Oncology
Mr. Aaron Bloomer	Chief Financial Officer
Dr. Jorge A. Garces Ph.D.	Chief Science Officer
Mr. Nassar Nizami	Chief Information Officer

Important FAQs about investing in EXAS Stock from India :

What is Exact Sciences share price today?

Exact Sciences share price today stands at $56.05, Open: $56.48 ; Previous Close: $56.03 ; High: $57.21 ; Low: $55.43 ; 52 Week High: $79.62 ; 52 Week Low: $40.62.

The stock opens at $56.48, after a previous close of $56.03. The stock reached a daily high of $57.21 and a low of $55.43, with a 52-week high of $79.62 and a 52-week low of $40.62.

Can Indians buy Exact Sciences shares?

Yes, Indians can invest in the Exact Sciences (EXAS) from India.

With INDmoney, you can buy Exact Sciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Exact Sciences at zero transaction cost.

How can I buy Exact Sciences shares from India?

It is very easy to buy Exact Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Exact Sciences (EXAS) be purchased?

Yes, you can buy fractional shares of Exact Sciences with INDmoney app.

What are the documents required to start investing in Exact Sciences stocks?

To start investing in Exact Sciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.